Texas Top Legal Officer Files Lawsuit Against Acetaminophen Manufacturers Concerning Autism Assertions
The top legal official in Texas Paxton is taking legal action against the makers of Tylenol, asserting the companies hid potential risks that the pain reliever presented to children's neurological development.
This legal action comes thirty days after Former President Trump publicized an unverified association between using acetaminophen - referred to as paracetamol - throughout gestation and autism in young ones.
Paxton is suing the pharmaceutical giant, which once produced the drug, the exclusive pain medication suggested for pregnant women, and the current manufacturer, which now manufacturers it.
In a official comment, he said they "betrayed America by profiting off of pain and marketing drugs without regard for the dangers."
The company says there is no credible evidence connecting Tylenol to autism spectrum disorder.
"These companies deceived for years, intentionally threatening countless individuals to boost earnings," Paxton, from the Republican party, declared.
The company stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the well-being of US mothers and children."
On its online platform, the company also stated it had "regularly reviewed the applicable studies and there is lacking reliable evidence that shows a proven link between consuming acetaminophen and autism spectrum disorder."
Associations acting on behalf of medical professionals and healthcare providers agree.
The leading OB-GYN organization has stated paracetamol - the key substance in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and fever, which can create major wellness concerns if not addressed.
"In more than two decades of research on the consumption of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the consumption of acetaminophen in any trimester of gestation results in neurological conditions in children," the association stated.
The court filing cites latest statements from the Trump administration in asserting the drug is allegedly unsafe.
In recent weeks, Trump generated worry from public health officials when he instructed expectant mothers to "fight like hell" not to use acetaminophen when sick.
The US Food and Drug Administration then published an announcement that doctors should contemplate reducing the use of acetaminophen, while also mentioning that "a proven link" between the drug and autism in minors has remains unverified.
The Health Department head RFK Jr, who supervises the Food and Drug Administration, had pledged in spring to conduct "extensive scientific investigation" that would determine the source of autism in a limited time.
But specialists advised that identifying a single cause of autism spectrum disorder - considered by experts to be the outcome of a complicated interplay of inherited and environmental factors - would not be simple.
Autism spectrum disorder is a type of permanent neurological difference and condition that impacts how people perceive and engage with the surroundings, and is recognized using medical professional evaluations.
In his lawsuit, Paxton - a Trump ally who is campaigning for federal office - claims Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.
The case attempts to require the corporations "eliminate any commercial messaging" that claims Tylenol is safe for expectant mothers.
This legal action mirrors the concerns of a assembly of guardians of young ones with autism and ADHD who sued the manufacturers of Tylenol in recently.
Judicial authorities threw out the lawsuit, saying studies from the parents' expert witnesses was inconclusive.
